Cargando…
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice
SIMPLE SUMMARY: We are entering an exciting new phase in the history of non-Hodgkin lymphoma treatment. Advances in monoclonal antibody-based therapies, which began with rituximab in the 1990s but have only recently started to show their full potential, along with the development of cellular therapi...
Autores principales: | Tavarozzi, Rita, Zacchi, Giulia, Pietrasanta, Daniela, Catania, Gioacchino, Castellino, Alessia, Monaco, Federico, Gandolfo, Carolina, Rivela, Paolo, Sofia, Antonella, Schiena, Noemi, Bertassello, Claudia, Limberti, Giulia, Zallio, Francesco, Zanni, Manuela, Ladetto, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670523/ https://www.ncbi.nlm.nih.gov/pubmed/38001657 http://dx.doi.org/10.3390/cancers15225397 |
Ejemplares similares
-
Infections and Follicular Lymphoma: is there a Link?
por: Zallio, Francesco, et al.
Publicado: (2017) -
Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case.
por: Tavarozzi, Rita, et al.
Publicado: (2021) -
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
por: Catania, Gioacchino, et al.
Publicado: (2016) -
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis
por: Marchetti, Monia, et al.
Publicado: (2022) -
The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
por: Tavarozzi, Rita, et al.
Publicado: (2022)